Use of real-world evidence for healthcare decision-making in the Middle East: practical considerations and future directions. (4th May 2019)
- Record Type:
- Journal Article
- Title:
- Use of real-world evidence for healthcare decision-making in the Middle East: practical considerations and future directions. (4th May 2019)
- Main Title:
- Use of real-world evidence for healthcare decision-making in the Middle East: practical considerations and future directions
- Authors:
- Akhras, Kasem S.
Alsheikh-Ali, Alawi A.
Kabbani, Samer - Abstract:
- ABSTRACT: Introduction : Real-world evidence (RWE) is increasingly being used in coverage, reimbursement and formulary decisions for medicines globally. Areas covered : The Middle East (ME) region is significantly behind in generating and using RWE in health policy decisions due to several factors that shaped the health sector over the past few decades. The trend, however, is changing due to several factors that are shaping the future of the healthcare industry in the region. Among other factors, rising healthcare cost, changing population and disease demographics, increased focus on the quality of healthcare, digitization of medical data, increased demand for local clinical and economic data, and overall greater influence of global trends in the healthcare industry. For the region to realize the benefit of RWE in healthcare decisions, it needs to overcome several challenges including embracing the value that RWE brings to healthcare decisions, building trust between stakeholders, establishing reliability and validity of databases used to generate RWE, enhancing technical capabilities, investing in local data generation, and conducting high-quality RWE studies while maintaining patients' confidentiality. Expert commentary : We believe that the next decade will witness significant increase in RWE generation in the region, and will play a key role in driving efficiency in healthcare delivery.
- Is Part Of:
- Expert review of pharmacoeconomics & outcomes research. Volume 19:Number 3(2019)
- Journal:
- Expert review of pharmacoeconomics & outcomes research
- Issue:
- Volume 19:Number 3(2019)
- Issue Display:
- Volume 19, Issue 3 (2019)
- Year:
- 2019
- Volume:
- 19
- Issue:
- 3
- Issue Sort Value:
- 2019-0019-0003-0000
- Page Start:
- 245
- Page End:
- 250
- Publication Date:
- 2019-05-04
- Subjects:
- Real-world evidence -- Middle East -- healthcare -- cost -- healthcare data -- digital health
Pharmacology -- Economic aspects -- Periodicals
338.47615105 - Journal URLs:
- http://www.future-drugs.com/loi/erp ↗
http://informahealthcare.com ↗ - DOI:
- 10.1080/14737167.2019.1568243 ↗
- Languages:
- English
- ISSNs:
- 1473-7167
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3842.002996
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 23796.xml